| 24.03.2023 21:00:01 | |
|---|---|
| Cena | |
| 152,65 USD | |
| Změna | 1,01% (1,52) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | NYSE |
| Měna | USD |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 368.364 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 152,30 USD (3.300) |
| Prodej (částka) | 152,90 USD (3.000) |
| Otevírací cena | 151,48 USD |
| Max | 152,76 USD |
| Min | 150,83 USD |
| Závěrečná cena (předchozí den) | 151,13 USD |
| Cena vážená obchodovaným objemem | 152,11957 USD |
| Objem (kusy) | 5.696.845 |
| Obchodovaný objem | 866.422.561,17 |
| Počet obchodů | 79.916 |
| Poslední zobchodovaný počet | 1.026.052 |
Futures a opce
| Související Futures | 15 |
| Související Opce | - |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON |  |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 16.03.2023 |
|
Global Equity Ratings |
|
| 10.03.2023 |
|
Global Equity Ratings |
|
| 27.02.2023 |
|
Global Equity Ratings |
|
| 07.02.2023 |
|
Global Equity Ratings |
|
| 30.01.2023 |
|
Global Equity Ratings |
|
Všechny burzy pro JOHNSON & JOHNSON
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Xetra | 24.03.2023 | 17:35 | 141,36 EUR | 1,04 | 364 |
| Vienna Stock Exchange | 24.03.2023 | 17:32 | 141,32 EUR | 0,00 | 2 |
| Tradegate | 24.03.2023 | 22:26 | 141,90 EUR | 1,60 | 252 |
| Stuttgart | 24.03.2023 | 17:30 | 141,24 EUR | 0,08 | 14 |
| SIX Swiss Exchange | 01.03.2023 | 17:36 | 500,00 CHF | 0,00 | 1 |
| SIX Swiss Exchange | 16.02.2023 | 17:35 | 175,00 USD | 0,00 | 1 |
| NYSE | 24.03.2023 | 21:00 | 152,65 USD | 866,42 | 79.916 |
| Munich | 24.03.2023 | 08:01 | 139,82 EUR | 0,00 | 1 |
| London Stock Exchange | 24.03.2023 | 17:35 | 152,01 USD | 0,15 | 19 |
| Hanover | 24.03.2023 | 09:09 | 139,98 EUR | 0,00 | 1 |
| Hamburg | 24.03.2023 | 17:31 | 141,40 EUR | 0,00 | 2 |
| Frankfurt | 24.03.2023 | 20:58 | 141,80 EUR | 0,11 | 11 |
| Duesseldorf | 24.03.2023 | 21:01 | 141,36 EUR | 0,00 | 11 |
| Berlin | 24.03.2023 | 08:08 | 139,80 EUR | 0,00 | 1 |
| BX Swiss | 23.03.2023 | 18:00 | 139,094 CHF | 0,02 | 1 |
| 24.03.2023 21:00:01 | |
|---|---|
| Cena | |
| 152,65 USD | |
| Změna | 1,01% (1,52) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | NYSE |
| Měna | USD |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 368.364 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 152,30 USD (3.300) |
| Prodej (částka) | 152,90 USD (3.000) |
| Otevírací cena | 151,48 USD |
| Max | 152,76 USD |
| Min | 150,83 USD |
| Závěrečná cena (předchozí den) | 151,13 USD |
| Cena vážená obchodovaným objemem | 152,11957 USD |
| Objem (kusy) | 5.696.845 |
| Obchodovaný objem | 866.422.561,17 |
| Počet obchodů | 79.916 |
| Poslední zobchodovaný počet | 1.026.052 |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | -8,44% | -12,89% | +28,08% |
| Výkonn. (abs.) | -14,07 | -22,59 | +33,47 |
| Beta | 0,39 | 0,35 | 0,44 |
| Volatilita | 15,45 | 16,72 | 18,15 |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 152,52 USD (7.639.536) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 155,27 USD (8.733.385) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 167,99 USD (7.536.543) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 170,85 USD (7.321.102) |
| YTD Max| datum | 180,93 USD (06.01.2023) |
| YTD Min | datum | 150,11 USD (23.03.2023) |
| 52týdenní max. | datum | 186,69 USD (25.04.2022) |
| 52týdenní min. | datum | 150,11 USD (23.03.2023) |
Logo společnosti
Kontakty
| JOHNSON & JOHNSON |
| - - |
| One Johnson & Johnson Plaza - 08933 New Brunswick |
| Telefon:+1-732-524-0400 |
| Fax:+ |
| E-mail:- |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON | |
Profil společnosti
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Womenšs Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. |
Členové představenstva
| A. Washington | Member of Board of Directors |
| Jennifer Doudna | Member of Board of Directors |
| Mark McClellan | Member of Board of Directors |
| Mary Beckerle | Member of Board of Directors |
| Nadja West | Member of Board of Directors |
| Paula Johnson | Member of Board of Directors |
| Anne Mulcahy | Member of Board of Directors |
| D. Davis | Member of Board of Directors |
| Darius Adamczyk | Member of Board of Directors |
| Hubert Joly | Member of Board of Directors |
| Ian Davis | Member of Board of Directors |
| Marillyn Hewson | Member of Board of Directors |
| Mark Weinberger | Member of Board of Directors |
| Joaquin Duato | Chairman of Managing Board |
| Mathai Mammen | Member of Executive Committee |
| Peter M. Fasolo | Member of Executive Committee |
| William N. Hait | Member of Executive Committee |
| Ashley McEvoy | Member of Executive Committee |
| James Swanson | Member of Executive Committee |
| Jennifer Taubert | Member of Executive Committee |
| Joseph Wolk | Member of Executive Committee |
| Kathryn E. Wengel | Member of Executive Committee |
| Michael H. Ullmann | Member of Executive Committee |
| Thibaut Mongon | Member of Executive Committee |
| Vanessa Broadhurst | Member of Executive Committee |